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Acyl-CoA desaturation in the endoplasmic reticulum (ER) membrane depends
on cytosolic NADH or NADPH, whereas NADPH in the ER lumen is uti-
lized by prereceptor glucocorticoid production. It was assumed that NADH
cytochrome b5 oxidoreductase (Ncb5or) might connect Acyl-CoA desaturation
to ER luminal redox. We aimed to clarify the ambiguous compartmentaliza-
tion of Ncb5or and test the possible effect of stearoyl-CoA on microsomal
NADPH level. Amino acid sequence analysis, fluorescence microscopy of
GFP-tagged protein, immunocytochemistry, and western blot analysis of sub-
cellular fractions unequivocally demonstrated that Ncb5or, either endogenous
or exogenous, is localized in the cytoplasm and not in the ER lumen in cul-
tured cells and liver tissue. Moreover, the involvement of ER-luminal reducing
equivalents in stearoyl-CoA desaturation was excluded.
Keywords: endoplasmic reticulum; fatty acid desaturation; glucocorticoid;
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Fatty acid synthesis yields saturated chains, domi-
nantly of 16 carbon atoms in human cells. Palmitoic
acid (C16 : 0) serves as the common endogenous pre-
cursor for various other nonessential fatty acids. Its
processing starts with an ATP-dependent activation,
that is, the formation of palmitoyl-CoA, and the inter-
mediates remain bound to the carrier molecule [1]. The
chain can be modified through variable sequences of
elongation (addition of two carbons) and desaturation
(changing a single into a double bond) [2]. Exogenous
essential or nonessential fatty acids are also attached
to CoA, and they can undergo the same intracellular
modifications to maintain a balanced fatty acyl-CoA
supply for the synthesis of complex lipids. The fatty
acyl-CoA elongase and desaturase enzyme systems are
embedded in the endoplasmic reticulum (ER) mem-
brane [2], and these transformations do not require the
acyl-CoA intermediates to cross the membrane and
enter the ER lumen [3].
Acyl-CoA desaturation means elimination of two
electrons (H atoms) from two neighboring carbon
atoms of the saturated chain. This oxidation is carried
out indirectly, through inserting an oxygen atom and
subsequently removing a water molecule. The remain-
ing oxygen atom of the substrate oxygen molecule
needs to be reduced, and hence the overall process
consumes the cell’s reducing power. Similarly to other
mono-oxygenases in the ER membrane (i.e., cyto-
chrome P450s), fatty acyl-CoA desaturases of human
and animal cells function as terminal members of elec-
tron transfer chains, which deliver two electrons from
NADH or NADPH to molecular oxygen [4].
Abbreviations
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The first double bond is formed at carbon 9 in the
saturated acyl-CoAs (palmitoyl- or rather stearoyl-
CoAs) by Stearoyl-CoA desaturase (SCD) (EC
1.14.99.5) [5]. Humans have two SCD homologues
(SCD1 and SCD5). The former is ubiquitous in the
organism and it is highly expressed in the liver and
adipose tissue, while the latter is mostly expressed in
the brain and pancreas [6]. The electron transfer chain
that connects NAD(P)H and the nonheme iron in the
active site of SCD1 comprises the flavoprotein cyto-
chrome b5 reductase (b5R) and the hemoprotein cyto-
chrome b5 (b5). These two monomeric dehydrogenase
enzymes are post-translationally targeted and get tail-
anchored into the ER membrane [7]. The amino-term-
inal bulk of their polypeptide chains, that is, the FAD-
containing catalytic domain of b5R [8] and the heme-
containing catalytic portion of b5 [9] are located at the
cytosolic side of the lipid bilayer. In accordance with
this membrane topology, it has been demonstrated
that acyl-CoA desaturation is driven by the cytosolic
rather than the ER luminal NAD(P)H pool [10–12].
The recent discovery of NADH cytochrome b5 oxi-
doreductase (Ncb5or; EC 1.6.2.2) has raised the possi-
bility that this novel enzyme might serve as an
alternative electron supplier for SCD1. Ncb5or is a
soluble natural fusion protein that integrates both
b5R-like and b5-like domains with FAD and heme
prosthetic groups, respectively. Cooperation of these
two domains can transfer electrons from NAD(P)H to
various artificial substrates [13]. Although the physio-
logical substrate(s) and the exact function of Ncb5or
remain to be elucidated, the domain structure of the
enzyme strongly suggests its role in fatty acid desatura-
tion. This theory is further supported by the pheno-
type of Ncb5or knock-out mice, which includes a
progressive loss of white adipose tissue along with a
pronounced reduction in the ratios of D9 desaturated
to saturated fatty acids in the liver [14].
Since the first report on the ER localization of
Ncb5or [15], the enzyme is generally referred to as a
microsomal oxidoreductase in accordance with its puta-
tive function. Microsomal localization of the particu-
late, that is, nonmembrane-bound Ncb5or protein
implies either its attachment to integral membrane pro-
teins on the cytosolic surface of the ER or its luminal
emplacement within the organelle. The former option
would only provide an alternative means of draining the
cytosolic reducing power toward SCD1; however, the
latter topology raises the intriguing possibility that ER
luminal NADPH may be utilized in the process of acyl-
CoA desaturation. The ER luminal NADP+:NADPH
redox state is a major determinant of prereceptor gluco-
corticoid production [16], that is, the concerted activity
of NADPH-dependent type 1 11b-hydroxysteroid dehy-
drogenase (11bHSD1) and NADP+-dependent hexose
6-phosphate dehydrogenase (H6PD) [17]. Draining
microsomal NADPH to acyl-CoA desaturation would,
therefore, create a direct link between cellular lipid
metabolism and local modulation of glucocorticoid hor-
mone action in the target cells.
It is essential to identify the subcellular compart-
ment that homes Ncb5or, and particularly to clarify
whether Ncb5or can access the separate NADPH pool
of the ER. The present work addressed these questions
by investigating the intracellular localization of overex-
pressed or endogenous Ncb5or in cultured cells and in
the liver tissue using fluorescent microscopy and cell
fractioning. The putative effect of stearoyl-CoA
administration on luminal [NADPH]:[NADP+] ratio
in liver microsomes has been also tested. Our results
unequivocally demonstrate that the novel oxidoreduc-
tase is a cytosolic enzyme, which has no access to the
luminal ER redox environment.
Materials and methods
Materials used
Lipofectamine 2000 and BODIPYTM TR-X thapsigargin
were purchased from Invitrogen. pcDNA3.1- and pEGFP-
N1 plasmids were from Clontech Laboratories, Inc.
(Mountain View, CA). Dulbecco’s modified Eagle’s med-
ium (DMEM), Opti-MEM, fetal bovine serum (FBS), 1%
antibiotic–antimycotic solution and trypsin-EDTA (0.25%)
were obtained from Thermo Fisher Scientific (Waltham,
MA). Cortisone, metyrapone, stearoyl-CoA, G6P, 4-mor-
pholinepropanesulfonic acid (MOPS) and 4-(2-Hydro-
xyethyl)piperazine-1-ethanesulfonic acid (HEPES) were
purchased from Sigma Chemical, St. Lous, MO.
Prediction of subcellular localization
The following computational tools were used to predict sub-
cellular targeting and localization of Ncb5or: BACELLO (http://
gpcr.biocomp.unibo.it/bacello), CELLO v.2.5 (http://cello.life.
nctu.edu.tw/), ESLDB (http://gpcr.biocomp.unibo.it/esldb/),
EUK-MPLOC 2.0 (http://www.csbio.sjtu.edu.cn/bioinf/euk-
multi-2), PROTEINPROWLER (http://bioinf.scmb.uq.edu.au:80
80/pprowler_webapp_1-2), and YLOC (http://abi.inf.uni-tuebi
ngen.de/Services/YLoc/webloc.cgi).
Expression plasmid constructions
The coding sequence of human NCB5OR was PCR ampli-
fied by using NCB5OR-XhoI sense (50-AAA TTT CTC
GAG GGG TTT GAA GAT GCT GAA C-30) and
NCB5OR-HindIII antisense (50-AAA TTT AAG CTT
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GTT GAA TAA AGG ACA ATG ACA G-30) primers.
The template cDNA had been produced by reverse tran-
scription of mRNA isolated from HepG2 cells. The purified
PCR product was cloned into pcDNA3.1- and pEGFP-N1
plasmids between their XhoI and HindIII restriction sites.
All constructs were verified by sequencing.
Cell cultures, transient transfection and lysis
Human embryonic kidney (HEK) 293T cells and hepatocel-
lular carcinoma (HepG2) cells were cultured in Dulbecco’s
modified Eagle medium (DMEM) supplemented with 10%
fetal bovine serum and 1% penicillin/streptomycin solution
at 37 °C in a humidified atmosphere containing 5% CO2.
For transient transfection, 6 9 105 HEK293T cells were
seeded per well in 6-well plates. Transfection with
pcDNA3.1-_NCB5OR, pEGFP-N1_NCB5OR, or empty
pEGFP-N1 plasmid (2 lg each) was performed using Lipo-
fectamine 2000 and Opti-MEM according to the manufac-
turer’s instructions. Transfected and parallelly cultured
nontransfected (control) cells were processed 48 h after
transfection.
Cell lysates were made for western blot analysis by
removing the medium, washing the wells with PBS twice
and then scraping and briefly vortexing the cells in 100 lL
reporter lysis buffer (Promega, Madison, WI, USA). After
15 min incubation at room temperature, the lysates were
centrifuged for 5 min at max speed in a benchtop cen-
trifuge at 4 °C to remove cell debris. Protein concentration
of the supernatants was measured using Pierce BCA Pro-
tein Assay Kit (Thermo Scientific, Waltman, MA, USA).
Analysis of Ncb5or-EGFP fusion protein
Expression of fluorescent Ncb5or-EGFP fusion protein was
analyzed in pEGFP-N1_NCB5OR-transfected HEK293T
cells. Forty-eight hours after transfection, cells were washed
three times with PBS and fixed in 3.7% formaldehyde for
10 min. After washing in PBS, cells were permeabilized
with 0.2% Triton X-100 in PBS for 5 min and then washed
in PBS again. Nuclei were stained with DAPI (2 lgmL1,
5 min), the cells were rinsed with PBS, and the ER was
labeled with BODIPYTM TR-X thapsigargin (1 lM). Images
were taken immediately by using a fluorescence microscope
(Leica DMI6000 B with DFCU80 camera) before the devel-
opment of ER stress-related morphological changes. Trans-
fection efficiency, that is, the relative number of EGFP-
positive cells was above 80%.
Integrity of Ncb5or-EGFP fusion protein in the cells was
verified by SDS/PAGE and autofluorescence detection. Cell
lysates were prepared by freeze-thawing, cell debris was
removed by centrifuging, and the supernatant was prepared
without DTT and heat denaturation for separation in SDS/
PAGE. Fluorescence was detected and gel images were pro-
duced by scanning in Typhoon 9400 variable mode imager
(Amersham Biosciences, Freiburg, Germany) at 488-nm
excitation and 509-nm emission wavelengths.
Separation of subcellular fractions by differential
centrifugation
The presence of endogenous Ncb5or was tested in various
subcellular (i.e., nuclear, mitochondrial, microsomal, and
cytosolic) fractions prepared from nontransfected HEK293
and HepG2 cells as well as from rat livers. HEK293 and
HepG2 cells were washed twice, scraped in 1 mL PBS and
disrupted by using a Dounce homogenizer. Livers of over-
night fasted male Wistar rats (200–250 g body weight) were
removed immediately after decapitation of the animals, and
they were homogenized in sucrose-HEPES buffer (0.3 M
sucrose, 0.02 M HEPES, pH 7.2) buffer by Potter-Elvehjem
homogenizer. Cell/tissue debris was sedimented from the
homogenates (800 g, 2 min, 4 °C), and the supernatant was
subjected to repeated centrifugations of increasing force.
The pellet was removed each time and yielded the fractions
of nuclei (1000 g, 10 min, 4 °C), mitochondria (11 000 g,
20 min, 4 °C) and microsomes (100 000 g, 1 h, 4 °C), while
the cytosolic fraction was gained as the remaining super-
natant. Aliquots of each fraction (100 lL) were precipitated
with 10% TCA, and the pellets were dissolved in 20 lL
sample buffer for western blot analysis. Rat liver micro-
somes were resuspended in MOPS-KCl buffer (100 mM
KCl, 20 mM NaCl, 1 mM MgCl2, and 20 mM MOPS, pH
7.2), rapidly frozen and stored in liquid N2 until used. Pro-
tein concentration of the microsomes was determined with
Bio-Rad protein assay solution using bovine serum albumin
as a standard according to the manufacturer’s instructions.
The origin and purity of each subcellular fraction was
confirmed by immunoblot using primary antibodies specific
to organelle-specific marker proteins (nucleus: CREB-1 and
Lamin A/C; mitochondria: Bcl-XL and Cyclophilin D;
cytoplasm: procaspase-3 and GAPDH; ER: PDI).
Western blot analysis
Cell lysates (50 lg protein) and samples of subcellular frac-
tions were electrophoresed in 12% Tris-glycine minigels
and transferred onto Immobilon-P membranes (Millipore,
Billerica, MA). The membranes were blocked with 5%
nonfat milk powder in phosphate-buffered saline in 0.1%
Tween-20 (PBST) solution for 1 h. Primary antibodies were
applied overnight at 4 °C, and secondary antibodies for 1 h
at room temperature. Primary antibodies and their dilu-
tions: anti-CREB1 (Santa Cruz, sc271), 1 : 2000; anti-
Lamin A/C (Cell Signaling, 4777), 1 : 1000; anti-Bcl-XL
(Santa Cruz, sc8392), 1 : 1000; anti-Cyclophilin D (MitoS-
ciences, MSA04), 1 : 1000; anti-PDI (Santa Cruz, sc20132),
1 : 4000; anti-procaspase-3 (Santa Cruz, sc7272), 1 : 4000;
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anti-Ncb5or (Santa Cruz, sc-100529 and sc-68684),
1 : 2000, anti-GAPDH (Santa Cruz, 6C5), 1 : 20 000; anti-
SCD1 (Abcam, ab19862), 1 : 4000. HRP-conjugated goat
anti-(rabbit IgG), horse- anti-(mouse IgG), and donkey
anti-(goat IgG) antibodies were purchased from Cell Sig-
naling (7074S; 7076S) and Santa Cruz Biotechnology (sc-
2020). They were applied at 1 : 2000 dilution. HRP was
detected using SuperSignal West Pico Chemiluminescent
Substrate (Pierce).
Immunofluorescence staining and fluorescent
microscopy in HepG2 cells
The HepG2 cells were grown on microscope slides in
humidity chamber for 6 h. The cells were then fixed in
methanol-acetone (1 : 1) for 10 min at room temperature
(RT), washed three times 5-min in PBS, permeabilized and
blocked in DAKO serum-free protein blocking solution
(code: X0909; DAKO, Glostrup, Denmark) for 1 h at RT.
Cells were then incubated with the appropriate primary
antibodies overnight at 4 °C, followed by staining with flu-
orochrome-labeled secondary antibodies for 1 h. Primary
antibodies were mouse monoclonal antibody against human
Ncb5or (1 : 200 dilution; Santa Cruz Biotechnology; sc-
100529) and rabbit polyclonal antibody against PDI
(1 : 100 dilution; Santa Cruz Biotechnology; sc-20132).
Alexa Fluor 488 donkey anti-(mouse IgG) and Alexa Fluor
568 goat anti-(rabbit IgG) (Life Technologies, Walthman,
MA, USA) fluorescent secondary antibodies were used
(both diluted 1 : 200). Coverslips were mounted on glass
slides with 40,6-diamidin-2-phenylindol (DAPI) containing
Vecteshield mounting medium from Vector Laboratories
(Burlingame, CA). Fluorescent microscopy was performed
using a Leica DM RXA motorized fluorescent microscope
(Leica Microsystems GmbH, Wetzlar, Germany) equipped
with Spectrum Orange, Spectrum Green, single bandpass,
and DAPI single longpass filters, as well as DAPI/FITC/
Texas Red triple bandpass filter. Nomarski differential
interference contrast (DIC) technique was used to visualize
the cells and their borders for the precise localization
results. Images were taken at 630-fold magnification by a
Leica DFC 365FX high performance monochrome CCD
camera controlled by Leica CW4000 FISH software (Leica
Microsystems Imaging Solutions Ltd., Cambridge, UK).
Fluorimetric detection of microsomal NADH and
NADPH
Endogenous reduced pyridine nucleotide content of intact
rat liver microsomes was monitored at 1 mgmL1 protein
concentration in MOPS-KCl buffer at 37 °C by fluorime-
try. NAD(P)H-specific fluorescence was detected at 340-nm
excitation and 460-nm emission wavelengths using a Cary
Eclipse spectrofluorimeter (Varian, Woburn, MA). Oxida-
tion of the luminal pyridine nucleotide pool was induced
by metyrapone (5 lM) or cortisone (10 lM) and this effect
was reverted by G6P (100 lM). Stearoyl-CoA was adminis-
tered at various concentrations below 100 lM.
Results
In silico prediction of subcellular localization
Elucidated amino acid sequence of human Ncb5or
[NCBI: NP_057314.2] was analyzed by computational
tools to identify any ER-targeting signals and to pre-
dict the subcellular localization of the protein. The
results obtained from six online localization predictors
are summarized in Table 1. These tools employ vari-
ous well-documented methods including homology-
based annotations, analysis of whole sequence amino
acid composition, search for sorting signals and func-
tional motifs. None of the applied tools revealed signal
peptide or ER-retention signal in the polypeptide.
Although the possibility of mitochondrial or nuclear
localization was also speculated as second or third
options, the most likely topology of Ncb5or protein
was unequivocally predicted to be cytoplasmic
(Table 1).
Expression and fluorescent detection of Ncb5or-
EGFP fusion protein in HEK293T cells
The HEK293T cells were transiently transfected with
pcDNA3.1-_NCB5OR, pEGFP-N1_NCB5OR, or
empty pEGFP-N1 plasmid constructs to express
exogenous human Ncb5or, Ncb5or-EGFP fusion pro-
tein, or EGFP, respectively. Prior to fluorescence
microscopy, the expression, stability and intactness of
Ncb5or-EGFP was tested using gel electrophoresis and
autofluorescence detection as well as immunoblot with
anti-Ncb5or primary antibody. Fluorescent signals of
EGFP (27 kDa) and Ncb5or-EGFP (86 kDa) were
clearly visible at the appropriate molecular weights in
polyacrylamide gels after separation (Fig. 1A). Most
importantly, the 27 kDa band corresponding to EGFP
alone was not detectable in the samples prepared from
Ncb5or-EGFP-expressing cells, which indicates the
lack of significant intracellular breakage of the tagged
protein. A small amount of endogenous Ncb5or
was revealed in the protein lysates of control
(untransfected) cells by western blot analysis. As it was
expected, the overexpression of untagged Ncb5or was
demonstrated by a largely intensified band of the same
molecular weight (59 kDa) in pcDNA3.1-_NCB5OR-
transfected cells (Fig. 1B). The applied anti-Ncb5or
primary antibody yielded two bands in the samples of
pEGFP-N1_NCB5OR-transfected cells: the stronger
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one indicates EGFP-tagged protein of 86 kDa, while
the fainter one can be identified as the 59 kDa Ncb5or
without EGFP-tag. The latter did not significantly
exceed the endogenous expression seen in the control
samples, which further supports the stability of
Ncb5or-EGFP polypeptide (Fig. 1B).
After having verified that pEGFP-N1_NCB5OR-
transfected cells are free of interfering protein degrada-
tion products, and EGFP-specific fluorescence corre-
sponds to Ncb5or-EGFP, these cells were examined by
flurescence microscopy. Green autofluorescence was
observed in more than 80 of 100 investigated cells, that
is, the transfection efficiency was above 80%. The sig-
nal was diffuse in the cytoplasm (Fig. 2), and it did
not colocalize with fluorescent staining of either the
nuclei (DAPI, blue) or the ER (BODIPYTM TR-X
thapsigargin, red).
Ncb5or immunoblot in isolated subcellular
fractions
Intracellular localization of Ncb5or was further ana-
lyzed by detecting the endogenously expressed protein
in subcellular fractions prepared by differential cen-
trifugation from HEK293 and HepG2 cells as well as
from rat livers. Proteins of well-defined localization
and regarded as characteristic to different cellular
compartments or organelles were employed as mark-
ers specific to each fraction in our experiments. The
markers of nuclei (CREB-1 and Lamin A/C), ER
(PDI) and cytosol (Procaspase-3 and GAPDH) were
detected only in the appropriate samples, while some
contamination of nuclear fractions with mitochondria
was indicated by the presence of mitochondrial mark-
ers (Bcl-XL or Cyclophilin D) in both lanes, mostly
in HEK293 and rat liver samples (Fig. 3). This, how-
ever, did not disturb the evaluation of our assay as
Ncb5or protein could be detected only in the cytoso-
lic fractions of both of the cultured cells and of rat
livers.
Fig. 1. Expression and integrity of Ncb5or-EGFP fusion protein.
Control (nontransfected) and transfected (p.NCB5OR, p.EGFP, or
p.NCB5OR-EGFP) HEK293T cells were harvested and lysed 48 h
after transfection. Equal amounts of proteins (50 lg) were
electrophoresed in a 12% SDS-polyacrylamide gel, and (A) their
green fluorescence was scanned by a gel imager at 488-nm
excitation and 509-nm emission wavelengths, or (B) they were
transferred to Immobilon-P membrane and visualized by western
blot using an anti-Ncb5or antibody. The calculated weights of
Ncb5or-EGFP fusion protein, Ncb5or and EGFP, are 86 kDa, 59
kDa and 27 kDa, respectively. Typical results of three independent
experiments are shown.
Table 1. Prediction of subcellular localization of human Ncb5or
Software Localization Basis of prediction
eSLDB Cytoplasm Homology-based
annotations (28)
CELLO v.2.5 Cytoplasm
RELIABILITY:
Cytoplasmic 1.969
Nuclear 1.510
Mitochondrial 1.092
Peroxisomal 0.049
PlasmaMembrane
0.048
ER 0.032
Amino acid composition,
the partitioned amino
acid composition and the
sequence composition
based on the physico-
chemical properties of
amino acids (29)
YLoc Cytoplasm
PROBABILITY:
Cytoplasm 84.6%
Mitochondrion 9.1%
Nucleus 6.3%
Secretory pathway
0.0%
Sequence-based
predictions (amino acid
composition, sorting
signals) (30)
BaCelLo Cytoplasm
LOCALIZATION
STEPS:
Intracellular ?
Nucleus or
Cytoplasm ?
Cytoplasm
Amino acid compositions
of both the N- and C-
terminal (31)
Euk-mPLoc
2.0
Cytoplasm Gene ontology, functional
domains and sequential
evolutionary information
(32)
ProteinProwler Cytoplasm N-terminal sequence
motifs (33)
The entire amino acid sequence of human Ncb5or [NCBI:
NP_057314.2] was analyzed by six online computational softwares
employing different algorithms (see references) to predict the sub-
cellular localization of the protein. Further details of the output are
shown where available.
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Immunocytochemistry of endogenous Ncb5or in
HepG2 cells
To avoid the drawbacks of exogenous overexpression
and peptide tagging that might affect intracellular pro-
tein targeting, while taking advantage of in situ analysis,
endogenously expressed naive Ncb5or was immunola-
beled and localized by fluorescence microscopy in
untreated and untransfected HepG2 cells (Fig. 4).
A
B C
D E
Fig. 2. In situ localization of Ncb5or-EGFP
fusion protein in HEK293T cells. (A)
HEK293T cells were transfected with
p.NCB5OR-EGFP construct and studied by
fluorescence microscopy 48 h after
transfection. (B) Endoplasmic reticulum
was labeled with BODIPYTM TR-X (red).
(C) Nuclei were stained with DAPI (blue).
(D) Green fluorescence of Ncb5or-EGFP
fusion protein was detected in more than
80 of 100 cells (above 80% transfection
efficiency). (E) merged image of B, C, and
D. Typical results of four independent
experiments are shown.
Fig. 3. Detection of endogenous Ncb5or protein in different subcellular fractions. HEK293 and HepG2 cells (A) and rat liver tissue (B) were
homogenized and their subcellular fractions were separated by differential centrifugation. Aliquots of each fraction were subjected to SDS/
PAGE, transferred to Immobilon-P membrane and analyzed by immunoblot. CREB1 (cAMP-responsive element-binding protein 1) and Lamin
A/C nuclear, Bcl-XL (B-cell lymphoma-extra large) and Cyclophilin D mitochondrial, PDI (Protein disulfide isomerase) microsomal, procaspase-
3 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cytosolic markers as well as Ncb5or were detected by using specific primary
antibodies. Typical results of four independent experiments are shown.
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The specific (green) signal for Ncb5or was seen to be
disseminated in the cytosol, showing a clearly different
pattern compared to the ER labeling (red). The
Nomarski DIC technique is capable to visualize cells and
their borders by transforming the invisible optical density
differences into visible, relief-like picture of the object.
Endogenous expression of Ncb5or was demonstrated to
be quite low by immunocytochemistry. However speci-
ficity of this weak staining was supported by the fact that
the small green dots corresponding the Ncb5or-specific
signals were definitely localized within the Nomarski
DIC visualized cell borders. In certain cells, Ncb5or
seemed to be localized in the processes of the cytoplasm
as well, while others lacked the Ncb5or protein in their
cytoplasmic extensions. Accumulation of Ncb5or at the
nuclear border was also observed in a few cells. Never-
theless, the protein did not show obvious colocalization
with either the nuclear staining or the ER labeling.
Effect of stearoyl-CoA on the microsomal
pyridine nucleotides
Although the above data did not support the
assumption that Ncb5or might create a link between
A B
C D
E F
G H
Fig. 4. Immunocytochemistry of
endogenous Ncb5or protein in HepG2
cells. Immunofluorescence shows the
subcellular localization of Ncb5or protein
(green) and the endoplasmic reticulum
(ER) marker protein disulfide isomerase
(PDI, red) in HepG2 cells (original
magnification: 6309). (A) Differential
interference contrast (DIC) image of
HepG2 cells. (B) The nuclei were stained
with DAPI. (C) Localization of Ncb5or
protein visualized by specific primary
antibody and Alexa 488-conjugated (green
fluorescent) secondary antibody. (D)
Endoplasmic reticulum was stained with a
specific antibody against PDI followed by a
secondary antibody labeled with Alexa 568
fluorescent red dye. (E, G) Merged images
of B, C, and D. (F, H) Merged DIC images
of B, C, and D. Typical results of three
independent experiments are shown.
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ER-luminal pyridine nucleotides and acyl-CoA desatu-
ration in the membrane, the possible effect of stearoyl-
CoA on the luminal redox state was checked in rat
liver microsomal vesicles. Ncb5or is assumed to substi-
tute for both b5 and b5R in the electron flow. The
presence of SCD1 in the microsome preparation was
first confirmed by western blot analysis using anti-
SCD1 antibody and a lysate of SCD1-transfected
HEK293T cells for positive control (Fig. 5D). The
well-established method based on continuous fluori-
metric monitoring of intrinsic luminal NADH and
NADPH is suitable to reveal redox shifting inside the
vesicles (Fig. 5). Oxidation was clearly detected upon
the addition of metyrapone or cortisone (substrates of
11bHSD1) and their effect could be antagonized by
glucose-6-phosphate (a substrate of H6PD). However,
fluorescence was not altered by repeated addition of
stearoyl-CoA, that is, the luminal NAD(P)H level
remained unaffected by the substrate of microsomal
stearoyl-CoA desaturase (Fig. 5).
Discussion
Controversial data have been published regarding the
subcellular topology of Ncb5or. The first report on
the newly discovered protein demonstrated its cytoso-
lic perinuclear localization [18]. These findings were
revised 5 years later, and Ncb5or was shown to be
localized in the ER by using immunocytochemistry
on COS-7 cells expressing exogenous human trun-
cated c-myc-tagged Ncb5or, which was also sup-
ported by the enzyme’s colocalization with
calreticulin [15]. The question has not been addressed
again, and Ncb5or is now generally considered as a
microsomal enzyme, which implies its ER luminal
emplacement considering the lack of transmembrane
domains and membrane-anchoring moieties in the
single polypeptide.
Particulate microsomal proteins usually contain two
targeting signals, an amino-terminal or internal signal
peptide [19] and a carboxyl-terminal ER retention sig-
nal [20]. The lack of established ER retention signals
in the polypeptide chain does not on its own rule out
the localization in the lumen of the organelle. For
instance, the ER location of microsomal glu-
curonidase, void of any intrinsic ER retention
sequence, is a secondary result of association with ega-
syn, which is retained within the lumen of the ER [21]
via an HTEL ER retention sequence [22]. However,
the signal peptide is considered as a structural feature
both necessary and sufficient for ER-targeting [19]. It
is not surprising, therefore, that in silico peptide analy-
sis using various tools unequivocally predict against
ER-targeting of Ncb5or as it possesses neither signal
peptide nor retention sequence.
Although the physiologically interacting protein
partners of Ncb5or have not been identified, the pres-
ence of both b5R-like and b5-like domains in the
polypeptide and the data obtained from in vitro activ-
ity measurements suggest the involvement of the
enzyme in fatty acyl-CoA desaturation as an alterna-
tive electron supplier. This hypothesis is further sup-
ported by the phenotype of Ncb5or/ mice showing
a characteristic alteration of saturated-unsaturated
fatty acid profile. Since the reactions of acyl-CoA
desaturation take place at the interface of two cellular
compartments of separate pyridine nucleotide pools, it
Fig. 5. Modulation of NADPH level in the microsomal lumen.
Endogenous NADPH content of intact rat liver microsomal vesicles
was monitored at 1 mgmL1 protein concentration in MOPS-KCl
buffer by detecting fluorescence at 340 nm excitation and 460 nm
emission wavelengths. A decrease in the fluorescence signal
corresponds to the oxidation of luminal pyridine nucleotides.
Cortisone (A) and metyrapone (B) were added at 10 lM final
concentration and followed by 100 lM glucose 6-phosphate (A and
B) as indicated by the arrows. Stearoyl-CoA (C) was administered
repeatedly (first at 10 lM and then at 50 lM concentration). (D)
Western blot analysis of the microsome preparation using anti-
SCD1 antibody and a lysate of SCD1-transfected HEK293T cells
(SCD1 TF) for positive control. Typical results of three independent
experiments are shown.
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is a highly relevant question whether the acyl-CoA
desaturation is driven by cytosolic or ER luminal
NAD(P)H. The ER membrane is not permeable to
pyridine nucleotides (i.e., NAD+, NADH, NADP+,
and NADPH). Therefore, the ER luminal NAD(P)+-
NAD(P)H redox cycles are largely independent of the
cytosolic redox conditions [23]. The best known and
quantitatively by far the most important NADPH
consuming reaction is the reduction of cortisone to
cortisol by 11bHSD1 in the ER lumen of most tissues
(e.g., liver, muscle, adipose tissue). This in turn is
fueled by local NADPH production, which is main-
tained by the luminal NADP+-dependent H6PD [17].
The concerted action of these two coupled enzymes is
responsible for the prereceptor cortisol generation,
and hence it largely affects the local glucocorticoid
action in most hormone-targeted tissues. It has been
demonstrated that modulations in the redox state of
ER luminal pyridine nucleotides contribute to nutrient
sensing by the organelle [16]. Moreover, mounting evi-
dence support the role of microsomal prereceptor cor-
tisol production in the metabolic syndrome [24].
Therefore, any relationship between the separate ER
luminal pyridine nucleotide redox system and fatty
acid desaturation would clearly provide a means by
which saturated fatty acids can directly interact with
the hormonal control of major cellular functions, and
this option would give new perspectives to lipotoxicity
research.
The possibility that Ncb5or might link ER luminal
redox to acyl-CoA desaturation was suggested by all
available data regarding Ncb5or (i.e., NADH- or
NADPH-dependence, interacting domains similar to
b5R and b5, microsomal localization, defective fatty
acid desaturation, increased lipotoxicity and diabetes
in the knockout animals). Therefore, we aimed to
clarify the ambiguous subcellular topology of this
soluble protein. We addressed the question by using
fluorescence microscopy of GFP-tagged fusion pro-
tein, immunocytochemistry and western blot analysis
of subcellular fractions prepared from cultured cells
or liver tissue. Our results unequivocally demon-
strated the cytosolic localization of either exogenous
and tagged or endogenous and naive Ncb5or. The
possible effect of stearoyl-CoA on the ER luminal
pyridine nucleotides was also tested in liver micro-
somes. The well-established fluorescent method has
been repeatedly proven to reveal any redox shifting
in the intrinsic NAD(P)+-NAD(P)H pool upon the
activity of luminal dehydrogenases [25–27]. Cortisone
or metyrapone caused a remarkable oxidation of
NAD(P)H, which was reverted by glucose 6-phos-
phate; however, stearoyl-CoA remained ineffective,
further supporting the absence of Ncb5or in the
vesicles.
Our findings are not completely antagonistic to the
earlier report on the ER localization of Ncb5or [15].
We clearly showed the presence of this particulate
protein in the cytosolic compartment in HEK293 and
HepG2 cell lines as well as in rat liver tissue, and we
also demonstrated its absence within the liver microso-
mal vesicles. It cannot be ruled out, however, that in
certain metabolic conditions, Ncb5or might be in
direct physical contact with SCD1 in the ER mem-
brane and hence loosely and/or temporarily attached
to the outer surface of the ER. It seems plausible that
intensified acyl-CoA desaturase activity may summon
Ncb5or to reinforce the electron supply of SCD1, and
this could stabilize the attachment of the protein to
the ER membrane. The methodological differences
(e.g., different separation of subcellular organelles or
detection of another marker protein of the ER) do
not explain the antithetical conclusions of the previous
well-performed and correctly documented study on
the subcellular localization of Ncb5or [15] and the
present work. It is more likely that the cultured cells
and liver tissues were analyzed in distinct metabolic
states, that is, at different times after medium
exchange and different periods of fasting. The poten-
tial translocation of Ncb5or between the cytosol and
the ER membrane and its mechanisms deserve further
investigation.
Collectively, our results contradict the channeling of
ER luminal reducing equivalents into fatty acid desat-
uration by Ncb5or, and they strongly indicate the
cytosolic localization of the protein in accordance with
the lack of ER-targeting signals in the polypeptide. It
remains to be elucidated, how and in which conditions
Ncb5or participates in fatty acid desaturation as an
alternative cytosolic electron supplier. This activity
requires the protein to directly interact with integral
membrane proteins of the ER. It is, therefore, likely
that Ncb5or can be associated transiently to
the cytosolic surface of the organelle. Further study is
needed to reveal the contribution of this enzyme
to the protection of pancreatic b-cells against
lipotoxicity.
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